Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Taxes (2022 - 2025)

Sunshine Biopharma's Change in Taxes history spans 4 years, with the latest figure at -$152874.0 for Q4 2025.

  • For Q4 2025, Change in Taxes fell 81.02% year-over-year to -$152874.0; the TTM value through Sep 2025 reached $68422.0, down 75.85%, while the annual FY2024 figure was -$812080.0, 1008.69% down from the prior year.
  • Change in Taxes reached -$152874.0 in Q4 2025 per SBFM's latest filing, down from $162992.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $1.0 million in Q4 2023 to a low of -$1.2 million in Q2 2024.
  • Average Change in Taxes over 4 years is -$49742.2, with a median of -$40161.0 recorded in 2025.
  • Peak YoY movement for Change in Taxes: soared 323.55% in 2023, then plummeted 530.84% in 2024.
  • A 4-year view of Change in Taxes shows it stood at $238679.0 in 2022, then skyrocketed by 323.55% to $1.0 million in 2023, then plummeted by 108.35% to -$84452.0 in 2024, then tumbled by 81.02% to -$152874.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Change in Taxes are -$152874.0 (Q4 2025), $162992.0 (Q3 2025), and $30043.0 (Q2 2025).